Medical Director, Pathology Innovations bei natera
Physician-scientist and biotech executive driving innovation at the convergence of diagnostics, AI, and health policy. Proven ability to translate academic discovery into regulated, reimbursable, and scalable clinical products. Poised to lead an early-stage diagnostics company through its commercial transition, with a track record of bridging scientific innovation and business execution across the Atlantic. Recognized leader in transatlantic health data strategy. Driven by the conviction that innovation is the keystone of precision medicine.
Gesundheitsdaten gelten als Schlüssel für die Medizin der Zukunft – insbesondere in der Genomforschung. Bei seltenen Erkrankungen ermöglichen neue Verfahren wie die Ganzgenom-Sequenzierung erstmals eine schnelle und präzise Ursachendiagnostik. Statt jahrelanger diagnostischer Ody…
